Literature DB >> 11080546

Interactions between rewarding lateral hypothalamic and aversive nucleus reticularis gigantocellularis stimulation.

M Diotte1, M Miguelez, E Miliaressis, C Bielajew.   

Abstract

The interaction between rewarding and aversive consequences of brain stimulation were assessed in two studies. In the first, the frequency threshold for 300 ms trains of combined lateral hypothalamic (LH) and nucleus reticularis gigantocellularis (Gi) stimulation, in which each LH pulse was followed 2 ms later by the Gi one, was determined for one month. Compared to the threshold for trains of single LH pulses, combined LH-Gi stimulation initially increased the frequency threshold; however, this effect reversed within one session and was subsequently maintained for the duration of the study. The aversion produced by Gi stimulation, as measured by latency to escape, was abolished following a single session of LH-Gi pairs. In the second study, a subset of animals received both presentations of combined pulses, LH followed by Gi, and the reverse; the interval between pulses was varied from 0.2 to 6.4 ms. The effectiveness of combined stimulation, determined by the ratio of LH frequency thresholds to that of the LH-Gi ranged from 0 to 50% across animals but the individual effectiveness functions within animals did not vary with different intervals. In addition, the order of presentation of pulses was of no consequence. Thus, not only did exposure to LH stimulation appear to obliterate Gi aversion, but the combination of LH and Gi pulses added to the rewarding effect produced by LH stimulation alone.

Entities:  

Mesh:

Year:  2000        PMID: 11080546     DOI: 10.1016/s0166-4328(00)00268-0

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  1 in total

1.  Medial forebrain stimulation enhances intracranial nociception and attenuates morphine analgesia suggesting the existence of an endogenous opioid antagonist.

Authors:  Conan Kornetsky; Clifford M Knapp; Lisa Tozier; Arlene Pak
Journal:  Pharmacol Biochem Behav       Date:  2010-02-10       Impact factor: 3.533

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.